Orlen has reported a significant increase in financial performance, including a notable rise in EBITDA and plans for future investments including the New Chemistry project.
Orlen Group has reported extraordinary financial growth for the fourth quarter of 2025, achieving an EBITDA LIFO of 12.2 billion PLN, with a total EBITDA of 41.9 billion PLN for the year and net profits soaring to 11.2 billion PLN from just 2.6 billion PLN the previous year. This financial improvement is noteworthy considering the declining fuel prices. Orlen emphasizes that despite the challenging market conditions, their strategic initiatives and operational efficiencies have played a crucial role in enhancing their financial metrics.
In addition to these impressive financial results, Orlen plans to allocate 32.6 billion PLN towards investments in the forthcoming year, with a strong focus on the New Chemistry project. This initiative aims to diversify the company's portfolio and expand its presence in the chemical industry, highlighting Orlen's commitment to innovation and sustainable growth. The company anticipates substantial returns on these investments, which are expected to further bolster their market position.
Looking ahead, Orlen has identified key sectors where they expect to see significant benefits from their investments, including energy and materials. The company is preparing for crucial project completions that will align with their development strategy, reinforcing their expectation of maintained profitability and growth. Furthermore, the New Chemistry project is set to expand Orlen's operational capabilities, ensuring they meet future energy demands and contribute to the evolving chemical landscape.
